secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2022-02-15T23:59:59+00:00
Accession:  0001493152-22-004706
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic extends JH Darbie note maturity to Mar 2023; issues 33M warrants at $0.15
--------------------------------------------------------------------------------

- Maturity of convertible notes extended from March 31, 2022 to March 31, 2023 with all but one investor agreeing.
- Company to issue 33,000,066 Oncotelic warrants at an exercise price of $0.15 per common share.
- Each Unit holder receives 333,334 warrants per Unit purchased as consideration for the extension.
- Notes were originally issued in July 2020 as part of JH Darbie Financing units.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/0001493152-22-004706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315222004706/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-004706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer